Yu Zhang, Dimitrios Vagiannis, Youssif Budagaga, Ziba Sabet, Ivo Hanke, Tomáš Rozkoš, & Jakub Hofman. (2022). Encorafenib Acts as a Dual-Activity Chemosensitizer through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo. MDPI AG.
Chicago Style (17th ed.) CitationYu Zhang, Dimitrios Vagiannis, Youssif Budagaga, Ziba Sabet, Ivo Hanke, Tomáš Rozkoš, and Jakub Hofman. Encorafenib Acts as a Dual-Activity Chemosensitizer Through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo. MDPI AG, 2022.
MLA (9th ed.) CitationYu Zhang, et al. Encorafenib Acts as a Dual-Activity Chemosensitizer Through Its Inhibitory Effect on ABCC1 Transporter In Vitro and Ex Vivo. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.